Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients-Reference-Cited by-同舟云学术

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients

Published:2009-06 Issue:2 Volume:51 Page:163-174
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

DeJesus Edwin,Young Benjamin,Morales-Ramirez Javier O,Sloan Louis,Ward Douglas J,Flaherty John F,Ebrahimi Ramin,Maa Jen-Fue,Reilly Karen,Ecker Janet,McColl Damian,Seekins Daniel,Farajallah Awny

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference19 articles.

1. Adherence to HAART regimens.;Chesney;AIDS Patient Care STDS,2003

2. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy.;Stone;J Acquir Immune Defic Syndr,2004

3. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.;Gallant;N Engl J Med,2006

4. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral naive patients. Virologic, immunologic, and morphologic changes: a 96 week analysis.;Pozniak;J Acquir Immune Defic Syndr,2006

5. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen.;Mathias;J Acquir Immune Defic Syndr,2007

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pill Burden: A Major Barrier to HAART Adherence and Fixed Dose Combinations (FDCS) as its Solution – A Mini-Review;Current HIV Research;2024-05

2. Environmental pollution indices: a review on concentration of heavy metals in air, water, and soil near industrialization and urbanisation;Discover Environment;2024-01-25

3. Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program;AIDS and Behavior;2023-10-27

4. Patient-reported outcomes among virally suppressed people living with HIV after switching to Co-formulated bictegravir, emtricitabine and tenofovir alafenamide;Journal of Microbiology, Immunology and Infection;2023-06

5. First report of computational protein–ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients;Biochemistry and Biophysics Reports;2022-07